| Literature DB >> 30657019 |
Abstract
Proceedings of an Almirall-sponsored satellite symposium held at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Berlin, Germany, 10 October 2018.Entities:
Keywords: THC:CBD oromucosal spray; multiple sclerosis spasticity treatment; observational studies; randomized controlled trials
Year: 2019 PMID: 30657019 DOI: 10.2217/nmt-2018-0048
Source DB: PubMed Journal: Neurodegener Dis Manag ISSN: 1758-2024